Sure, all medical devices carry some risk. But when a company knows that a blood clot filter frequently fails, leading to many injuries and deaths, it isn’t a matter of reasonable risk. It’s a matter of holding the company accountable.
At , in New York City, we can help you pursue proper compensation after an injury or death caused by a failed blood clot filter. Our attorneys have a reputation for results in injury cases and offer a free initial meeting. Give us a call today to discuss your situation.
What Went Wrong With Your IVC?
IVC stands for interior vena cava, the large vein that carries blood from the lower part of the body to the heart. An IVC filter is supposed to prevent dangerous blog clots from reaching the heart and lungs. In recent years, about 250,000 Americans a year have had them implanted.
Unfortunately, IVC filters can backfire terribly.
- Breakage — IVC filters can pierce the heart or lungs if they break off. Nationally, many deaths have been associated with this.
- Movement — The movement of broken-off pieces can also result in other complications such as a stroke or a pulmonary embolism.
Symptoms of problems with a defective IVC filter can range from chest pain to severe internal bleeding. A failed IVC can also leave you helpless against the blood clots that led to the insertion of the IVC in the first place.
Eleven device companies make IVC filters, and any of them can be responsible for defective devices. Our law firm has the skill and experience in defective medical device cases to bring your case forward.
C.R. Bard’s Defective Devices
Of the 11 companies that make IVC filters, two of them have generated the most concern. They are Bard, the New Jersey-based medical device giant, and Cook Celect. In 2002, Bard got approval from the Food and Drug Administration to sell an IVC called the Recovery filter.
Reports began coming in that the device was linked to injuries and deaths. But the company kept selling Recovery filters for three more years.
In 2005, Bard replaced the Recovery with a similar filter series called the G2 that had many of the same problems. Bard continued to sell the G2 series until 2010.
The company did this despite documented reports that G2 filters broke off or moved within the body at excessive rates and had more health complications than other filters. Bard sold more than 160,000 of the G2 series filters during this time.
Taking Action Now
If you are outraged at corporate conduct like this, you have a right to be. And if you have been injured by it, you have a right to pursue full and fair compensation.